Citadel Advisors - MILESTONE PHARMACEUTICALS IN ownership

MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 38 filers reported holding MILESTONE PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of MILESTONE PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$934,672
-31.1%
301,507
-36.7%
0.00%
Q2 2023$1,356,457
-61.4%
475,950
-46.7%
0.00%
-100.0%
Q1 2023$3,517,210
+9.9%
892,693
+10.4%
0.00%0.0%
Q4 2022$3,200,907
-67.2%
808,310
-23.9%
0.00%
-50.0%
Q3 2022$9,763,000
+2208.0%
1,062,378
+1392.1%
0.00%
Q2 2022$423,000
+18.5%
71,200
+13.8%
0.00%
Q3 2021$357,000
-23.7%
62,566
-26.5%
0.00%
Q2 2021$468,000
+95.0%
85,100
+105.1%
0.00%
Q1 2021$240,000
+150.0%
41,500
+190.2%
0.00%
Q4 2020$96,00014,3000.00%
Other shareholders
MILESTONE PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Alta Fundamental Advisers LLC 1,176,189$3,646,1861.74%
Bleichroeder LP 1,326,085$4,110,8641.01%
BML Capital Management, LLC 272,500$844,7500.78%
VR Adviser, LLC 2,208,812$6,847,3170.72%
Lion Point Capital, LP 450,207$1,395,6420.62%
PVG ASSET MANAGEMENT CORP 15,405$47,7550.32%
Affinity Asset Advisors, LLC 335,068$1,038,7110.29%
RTW INVESTMENTS, LP 3,256,102$10,093,9160.21%
Ikarian Capital, LLC 462,828$1,434,7670.17%
Boxer Capital, LLC 309,007$957,9220.05%
View complete list of MILESTONE PHARMACEUTICALS IN shareholders